STAT+: Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
LONDON — Patients in England with a rare blood disorder will now be able to…
Category: CRISPR
STAT+: The race to build better CRISPR delivery vehicles is heating up
If the first CRISPR decade was marked by a mad dash to evolve, engineer, and…
STAT+: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub
Jiankui He, the Chinese scientist who sparked a global uproar in 2018 when he revealed…
STAT+: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice
Sonia Vallabh always thought genome editing wouldn’t be an option. It was such an obvious…
STAT+: Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial
Intellia Therapeutics said Saturday that the first 10 patients to receive a CRISPR-based treatment for…
STAT+: ChatGPT for genomes: introducing a CRISPR-designing generative AI
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived…
STAT+: First recipient of kidney transplant from genetically engineered pig has died, family says
Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has…
STAT+: CRISPR edits fail to cure HIV patients in early test
BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in…
STAT+: Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Three years ago, Moderna, flush with cash from Covid vaccine sales, announced it would start…
STAT+: Looking for signs of growth in Biogen’s earnings
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys
The ambitious idea of using CRISPR to cure genetic diseases before birth is one step…
Pfizer’s plot to win the RSV vaccine race
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Patient with transplanted pig kidney had a ‘tense’ rejection episode before leaving the hospital
The world’s first recipient of a kidney transplant from a genetically modified pig experienced a…
What ‘de-extinction’ of woolly mammoths can teach us: a Q&A with evolutionary biologist Beth Shapiro
Humans have long tinkered with the evolutionary trajectories of other species. Thousands of years ago…
EU adviser says Illumina merger was not problematic
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Listen: Live! From the STAT Breakthrough Summit East
Is there a cure for allergies? Has the FDA become too flexible? And which drugs…
Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?
CRISPR is no longer a promising but unproven technology — it is a reality. But…
STAT+: Feng Zhang suggests Editas didn’t move quickly enough to find product targets
When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas…
STAT+: Gene-edited pig kidney transplanted into a living patient for the first time
In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday…
Humira’s legacy, CEO symbolism, and genomic surgery
What do CEOs owe the world? Did Humira break the system? And can you CRISPR…
Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of…
STAT+: The Jewish American and Palestinian American scientists who’ve been partnering for 14 years on science’s toughest challenges
WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads…
Regeneron is interested in obesity treatments that combat muscle loss
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say
For three days in December, an ICU room at the Hospital of the University of…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FDA expands approval of CRISPR-based medicine to treat beta thalassemia
The Food and Drug Administration on Tuesday approved a CRISPR-based medicine to treat beta thalassemia,…
JPM Day 3 had a cautiously optimistic outlook
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution
Researchers attending gene therapy meetings over the past couple years were liable to bump into…
This is the TLDR of JPM Day 1
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff
Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve…
Why CG Oncology will be the first test of 2024’s IPO waters
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: 3 CRISPR advances to watch in 2024
Life in the CRISPR lane tends to move at lightning speed. This year saw the…
Morning Rounds: Our newsroom’s favorite stories of 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Morning Rounds: Why health care costs are nearly a fifth of the GDP
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes
Mary Brown was sipping coffee at home in Ontario, Calif., Sunday morning when a friend…
STAT+: 3 trends to watch in biotech in 2024
Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather in San Francisco to pick…
STAT+: European regulators endorse Casgevy, paving way for approval of CRISPR-based therapy
LONDON — The world’s first medicine based on the genome-editing technology CRISPR will almost certainly…
Is it time to worry about Moderna?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in
For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight…
A plot to solve the ‘whack-a-mole’ of drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Could sickle cell someday be treated not with CRISPR, but with a pill?
Two gene therapies were approved for sickle cell disease last week, but for many researchers…
Opinion: New sickle cell disease CRISPR treatments can’t make up for the shortage of adult hematologists
After decades of limited progress in the treatment of sickle cell disease (SCD), both patients…
Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH
SAN DIEGO — News of the Food and Drug Administration’s historic approval of the first…
STAT+: A Q&A with the CEO of CRISPR Therapeutics on a historic approval and the road ahead
Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame…
In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR…
Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…